Human Papillomavirus (HPV) Vaccine Market Analysis
The global Human Papillomavirus (HPV) Vaccine Market, valued at USD 4.12 billion in 2022, is expected to reach USD 10.64 billion by 2030, growing at a compound annual growth rate (CAGR) of 12.6% during the forecast period from 2023 to 2030.
HPV vaccines are critical in preventing infections caused by human papillomavirus, which is linked to...
0 Commentarios
0 Acciones
111 Views
0 Vista previa
Human Papillomavirus (HPV) Vaccine Market Size
The Human Papillomavirus (HPV) Vaccine Market, valued at USD 4.12 billion in 2022, is projected to reach USD 10.64 billion by 2030. This substantial growth reflects a compound annual growth rate (CAGR) of 12.6% over the forecast period from 2023 to 2030. The increasing prevalence of HPV-related diseases, coupled with heightened awareness and...